Ray Dalio Simulations Plus, Inc. Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$40.45 - $48.0 $95,340 - $113,136	-2,357 Reduced 7.05%	31,052 $1.35 Million
Q1 2023 May 12, 2023	SELL	$34.96 - $43.94 $19,402 - $24,386	-555 Reduced 1.63%	33,409 $1.47 Million
Q4 2022 Feb 13, 2023	SELL	$36.55 - $51.15 $380,046 - $531,857	-10,398 Reduced 23.44%	33,964 $1.24 Million
Q3 2022 Nov 10, 2022	BUY	$47.75 - $66.88 $1.47 Million - $2.06 Million	30,795 Added 226.98%	44,362 $2.15 Million
Q2 2022 Aug 11, 2022	SELL	$40.55 - $51.76 $1.22 Million - $1.56 Million	-30,047 Reduced 68.89%	13,567 $669,000
Q1 2022 May 13, 2022	BUY	$36.56 - $50.98 $377,152 - $525,909	10,316 Added 30.98%	43,614 $2.22 Million
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $128,106 - $198,374	-3,453 Reduced 9.4%	33,298 $1.58 Million
Q3 2021 Nov 12, 2021	SELL	$38.45 - $55.66 $14,957 - $21,651	-389 Reduced 1.05%	36,751 $1.45 Million
Q2 2021 Aug 13, 2021	BUY	$49.67 - $68.96 $1.84 Million - $2.56 Million	37,140 New	37,140 $2.04 Million

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.